• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

实施情况很重要:当遗传咨询伴随不确定意义的遗传变异结果返回时,患者体验有何不同。

Implementation matters: How patient experiences differ when genetic counseling accompanies the return of genetic variants of uncertain significance.

机构信息

University of Washington, Seattle Washington.

Kaiser Permanente Washington Health Research Institute, Seattle Washington.

出版信息

AMIA Annu Symp Proc. 2022 Feb 21;2021:950-958. eCollection 2021.

PMID:35309003
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8861684/
Abstract

Precision medicine presents challenges for effective return of results (ROR) to patients, particularly for variants of uncertain significance (VUS) where the need for genetic counseling and the impact of results are underexplored. We investigated patients' experiences with VUS ROR. Through interviews we compared experiences of patients who were referred to genetic counseling with those not referred. Although participants from both groups (n=16) reported curious enthusiasm and relief after ROR, the 5 referred participants reported less confusion, less disappointment, and better confidence in understanding their results than the 11 non-referred participants. Although VUS did not impact healthcare or daily lives, some participants who shared VUS fostered communication about future healthcare. Suggested ROR improvements included patient-friendly terminology, on-demand education, and ongoing consultation. Although patient experience of VUS improved when ROR involved expert consultation, scarcity of genetic counselors presents challenges. Improving the ROR process with patient-centered solutions could enhance the patient experience of receiving VUS.

摘要

精准医学对有效的结果回报 (ROR) 给患者带来了挑战,尤其是对于意义不确定的变异 (VUS),遗传咨询的需求和结果的影响尚未得到充分探索。我们调查了患者对 VUS ROR 的体验。通过访谈,我们比较了被转介至遗传咨询的患者与未被转介的患者的体验。尽管来自这两个组的参与者(n=16)在 ROR 后都报告了好奇的热情和宽慰,但与 11 名未被转介的参与者相比,5 名被转介的参与者报告的困惑较少、失望较少,对理解结果的信心更强。尽管 VUS 对医疗保健或日常生活没有影响,但一些分享 VUS 的参与者促进了未来医疗保健的沟通。建议的 ROR 改进包括患者友好的术语、按需教育和持续咨询。尽管当 ROR 涉及专家咨询时,患者对 VUS 的体验会有所改善,但遗传咨询师的稀缺性带来了挑战。通过以患者为中心的解决方案改进 ROR 流程,可以增强患者接受 VUS 的体验。

相似文献

1
Implementation matters: How patient experiences differ when genetic counseling accompanies the return of genetic variants of uncertain significance.实施情况很重要:当遗传咨询伴随不确定意义的遗传变异结果返回时,患者体验有何不同。
AMIA Annu Symp Proc. 2022 Feb 21;2021:950-958. eCollection 2021.
2
Genetic counselors' practices and confidence regarding variant of uncertain significance results and reclassification from BRCA testing.遗传咨询师对于意义未明变异结果以及BRCA检测重新分类的实践与信心。
Clin Genet. 2015 Dec;88(6):523-9. doi: 10.1111/cge.12563. Epub 2015 Feb 26.
3
Cancer patients' experience of receiving variant of uncertain significance results: An Asian perspective.癌症患者接受不确定意义变异结果的体验:亚洲视角。
J Genet Couns. 2024 Oct;33(5):985-994. doi: 10.1002/jgc4.1813. Epub 2023 Oct 21.
4
Genetic health professionals' experiences returning results from diagnostic genomic sequencing to patients.遗传健康专业人员向患者报告诊断性基因组测序结果的经验。
J Genet Couns. 2020 Oct;29(5):807-815. doi: 10.1002/jgc4.1209. Epub 2019 Dec 19.
5
Health behaviors among unaffected participants following receipt of variants of uncertain significance in cardiomyopathy-associated genes.不明意义突变相关基因心肌病检测结果为阴性的参与者的健康行为。
Genet Med. 2019 Mar;21(3):748-752. doi: 10.1038/s41436-018-0083-8. Epub 2018 Jul 12.
6
Patients' reactions and follow-up testing decisions related to Tay-Sachs (HEXA) variants of uncertain significance results.与意义未明的泰-萨克斯病(己糖胺酶A基因,HEXA)变异结果相关的患者反应及后续检测决策。
J Genet Couns. 2019 Aug;28(4):738-749. doi: 10.1002/jgc4.1108. Epub 2019 Mar 7.
7
Understanding and interpretation of a variant of uncertain significance (VUS) genetic test result by pediatric providers who do not specialize in genetics.非遗传学专业的儿科医疗人员对意义未明的变异(VUS)基因检测结果的理解与解读。
J Genet Couns. 2021 Dec;30(6):1559-1569. doi: 10.1002/jgc4.1422. Epub 2021 May 9.
8
The recommendation of re-classification of variants of uncertain significance (VUS) in adult genetic disorders patients.建议重新分类成人遗传性疾病患者中意义不确定的变异体(VUS)。
J Hum Genet. 2024 Sep;69(9):425-431. doi: 10.1038/s10038-024-01263-4. Epub 2024 Jun 6.
9
Understanding variants of uncertain significance in the era of multigene panels: Through the eyes of the patient.在多基因检测时代理解意义未明的变异:从患者的视角出发。
J Genet Couns. 2019 Aug;28(4):878-886. doi: 10.1002/jgc4.1130. Epub 2019 May 3.
10
Preimplantation genetic testing (PGT) for copy number variants of uncertain significance (CNV- VUS) in the genomic era: to do or not to do?植入前遗传学检测(PGT)在基因组时代对意义未明的拷贝数变异(CNV-VUS):做还是不做?
J Assist Reprod Genet. 2021 Mar;38(3):719-725. doi: 10.1007/s10815-020-02055-3. Epub 2021 Jan 14.

引用本文的文献

1
The NYCKidSeq randomized controlled trial: Impact of GUÍA digitally enhanced genetic results disclosure in diverse families.NYCKidSeq 随机对照试验:GUÍA 数字化增强遗传结果披露对不同家庭的影响。
Am J Hum Genet. 2023 Dec 7;110(12):2029-2041. doi: 10.1016/j.ajhg.2023.10.016. Epub 2023 Nov 24.

本文引用的文献

1
Is 'likely pathogenic' really 90% likely? Reclassification data in ClinVar.ClinVar 中的再分类数据:“可能致病”真的有 90%的可能性吗?
Genome Med. 2019 Nov 21;11(1):72. doi: 10.1186/s13073-019-0688-9.
2
Patient assessment of chatbots for the scalable delivery of genetic counseling.用于可扩展基因咨询服务的聊天机器人的患者评估
J Genet Couns. 2019 Dec;28(6):1166-1177. doi: 10.1002/jgc4.1169. Epub 2019 Sep 24.
3
Harmonizing Clinical Sequencing and Interpretation for the eMERGE III Network.协调 eMERGE III 网络的临床测序和解读。
Am J Hum Genet. 2019 Sep 5;105(3):588-605. doi: 10.1016/j.ajhg.2019.07.018. Epub 2019 Aug 22.
4
Patients' views on variants of uncertain significance across indications.患者对不同适应症中意义未明变异的看法。
J Community Genet. 2020 Apr;11(2):139-145. doi: 10.1007/s12687-019-00434-7. Epub 2019 Aug 20.
5
Patients' perspectives of variants of uncertain significance and strategies for uncertainty management.患者对意义未明变异的看法及不确定性管理策略。
J Genet Couns. 2019 Apr;28(2):313-325. doi: 10.1002/jgc4.1075. Epub 2019 Jan 12.
6
Impact of a Patient-Facing Enhanced Genomic Results Report to Improve Understanding, Engagement, and Communication.一份面向患者的增强型基因组结果报告对提高理解、参与度和沟通的影响。
J Genet Couns. 2018 Apr;27(2):358-369. doi: 10.1007/s10897-017-0176-6. Epub 2017 Dec 4.
7
A randomized controlled trial of disclosing genetic risk information for Alzheimer disease via telephone.一项通过电话披露阿尔茨海默病遗传风险信息的随机对照试验。
Genet Med. 2018 Jan;20(1):132-141. doi: 10.1038/gim.2017.103. Epub 2017 Jul 20.
8
Lynch Syndrome Limbo: Patient Understanding of Variants of Uncertain Significance.林奇综合征困境:患者对意义未明变异的理解
J Genet Couns. 2017 Aug;26(4):866-877. doi: 10.1007/s10897-017-0066-y. Epub 2017 Jan 26.
9
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2.0): a policy statement of the American College of Medical Genetics and Genomics.临床外显子组和基因组测序中次要发现报告的建议,2016年更新版(美国医学遗传学与基因组学学会次要发现v2.0):美国医学遗传学与基因组学学会政策声明
Genet Med. 2017 Feb;19(2):249-255. doi: 10.1038/gim.2016.190. Epub 2016 Nov 17.
10
My46: a Web-based tool for self-guided management of genomic test results in research and clinical settings.My46:一种用于在研究和临床环境中对基因组检测结果进行自我指导管理的基于网络的工具。
Genet Med. 2017 Apr;19(4):467-475. doi: 10.1038/gim.2016.133. Epub 2016 Sep 15.